Arlington closes $1.45bn sale of Riverpoint Medical to Novanta
Monday, July 27, 2026 · first reported by PE Hub
Arlington closes $1.45bn sale of Riverpoint Medical portfolio company to public acquirer Novanta.
- Firm
- Arlington
- Also named
- Riverpoint Medical, Novanta
- Deal value
- $1.4B
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Deals
From the same day- Blackstone, KKR and Brookfield agree $16bn Kuwait pipeline investmentPrivate Equity Wire
- ECP, KKR agree to acquire DCC Energy in $7.7bn dealPE Hub
- Carlyle and Bain Capital in final race for $7bn Wealth Enhancement dealPrivate Equity Wire
- EQT raises Perpetual offer to AUD2.55bn in third takeover approachPrivate Equity Wire
- TransDigm to acquire IGP-backed Prince & Izant for over $1bnPE Hub
- Bain Capital to acquire Vitabiotics in £900m dealPrivate Equity Wire